Lionco(SH:603669) Zheng Quan Ri Bao·2025-04-26 00:09Core Viewpoint - The company, Lingkang Pharmaceutical Group Co., Ltd., has released its quarterly report, ensuring the accuracy and completeness of the financial information presented, and confirming that there are no false records or significant omissions [2][3]. Financial Data Summary - The quarterly financial statements for the first quarter of 2025 are unaudited, with the company confirming that there were no profits from mergers under common control for the current and previous periods, both reporting a net profit of 0.00 yuan [6][7]. - The company holds 17,701,793 shares in its repurchase special securities account, representing 2.45% of the total circulating shares [4]. Shareholder Information - The report includes details on the total number of ordinary shareholders and the status of the top ten shareholders, although there were no changes reported in the lending or returning of shares by major shareholders [5].